Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avinger Inc (AVGR)

Avinger Inc (AVGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion (CTO) Image-Guided Crossing Device

REDWOOD CITY, CA / ACCESSWIRE / January 9, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...

AVGR : 1.14 (+6.54%)
Avinger Receives CE Marking for Ocelaris, a Next-Generation Image-Guided CTO Crossing System

REDWOOD CITY, CA / ACCESSWIRE / December 17, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems...

AVGR : 1.14 (+6.54%)
Avinger Appoints Healthcare Veteran Tamara Elias, MD, to Board of Directors

REDWOOD, CA / ACCESSWIRE / December 16, 2019 / Avinger, Inc. (NASDAQ:), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis...

AVGR : 1.14 (+6.54%)
Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

Zacks.com featured highlights include: Avinger, Alexion Pharmaceuticals, CyberArk Software, Organovo and Qualys

QLYS : 84.90 (-0.52%)
CYBR : 140.00 (-0.38%)
AVGR : 1.14 (+6.54%)
ONVO : 0.46 (unch)
ALXN : 113.27 (+0.68%)
What Bargain Hunting? Tap 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E for outsized gains.

QLYS : 84.90 (-0.52%)
CYBR : 140.00 (-0.38%)
AVGR : 1.14 (+6.54%)
ALXN : 113.27 (+0.68%)
ONVO : 0.46 (unch)
Avinger: 3Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Avinger Inc. (AVGR) on Tuesday reported a loss of $4.6 million in its third quarter.

AVGR : 1.14 (+6.54%)
Avinger Reports Third Quarter 2019 Financial Results

Increased Utilization Drives 33% Growth in Catheter Sales and Gross Margin Expansion

AVGR : 1.14 (+6.54%)
Try Rising P/E Investing With 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

TRIP : 30.93 (-1.87%)
NOW : 312.52 (+0.81%)
CHKP : 113.75 (-0.90%)
AVGR : 1.14 (+6.54%)
ALXN : 113.27 (+0.68%)
Avinger to Announce Third Quarter 2019 Financial Results on November 5, 2019

REDWOOD CITY, CA / ACCESSWIRE / October 29, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 1.14 (+6.54%)
Avinger (AVGR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AVGR : 1.14 (+6.54%)
Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

SPSC : 57.00 (-2.45%)
SWKS : 124.17 (+0.88%)
VAR : 149.00 (+0.17%)
AVGR : 1.14 (+6.54%)
TUES : 1.55 (-3.73%)
Avinger Announces Full Commercial Launch of Pantheris SV

Product Shipped to 25 U.S. Accounts

AVGR : 1.14 (+6.54%)
Avinger to Present at Ladenburg Thalmann Healthcare Conference on September 24

REDWOOD CITY, CA / ACCESSWIRE / September 17, 2019 / Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced today announced that...

AVGR : 1.14 (+6.54%)
Avinger Announces Commercial Launch and First Patients Treated in Hong Kong

REDWOOD CITY, CA / ACCESSWIRE / September 10, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis...

AVGR : 1.14 (+6.54%)
Avinger Supports Peripheral Artery Disease (PAD) Awareness Month with Physician and Patient Programs in September

REDWOOD CITY, CA / ACCESSWIRE / September 4, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system...

AVGR : 1.14 (+6.54%)
Avinger Announces 50th Patient Treated in Pantheris SV Initial Launch

Preparing for Full Commercial Launch in September

AVGR : 1.14 (+6.54%)
Avinger Closes $4.5 Million Equity Offering

Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 3,813,559 shares of its...

AVGR : 1.14 (+6.54%)
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock

Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pricing of an underwritten public offering with gross proceeds to the...

AVGR : 1.14 (+6.54%)
Avinger Announces Proposed Underwritten Public Offering of Common Stock

Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends to offer shares of its common stock for sale in an underwritten...

AVGR : 1.14 (+6.54%)
Avinger Announces Presentations by Key Opinion Leaders at AMP 2019 Clinical Conference

REDWOOD, CA / ACCESSWIRE / August 19, 2019 / Avinger, Inc. (NASDAQ:), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for the diagnosis...

AVGR : 1.14 (+6.54%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -0.35 , SEDG +2.05 , THC unch , TER -0.21 , LITE -0.79
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar